The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
04 Dec 2020
Cancer Control Policy Interview Survey (CCPIS) Report endorsed and finalised
Work Package 4 team conducted a detailed cancer control policy interview survey by visiting 28 European countries in order to collect information on current initiatives and experience in implementing cancer control policies in EU Member States. The outcomes of this exercise are summarized in the Cancer Control Policy Interview Survey (CCPIS) Report.
09 Nov 2020
Basket of good news at the 5th Governmental Board meeting
The 5th iPAAC Governmental Board meeting was held online on 1st of October 2020. The meeting brought together Member State Representatives, iPAAC Work Package Leaders and European Commission Representatives.
04 Nov 2020
Reimbursement models for cancer surgery and radiation oncology
The evolving field of cancer therapy poses a real challenge for designing a reimbursement policy that can cope with providing a fair payment of the evidence-based standard of care and with the rapid pace of innovation.
14 Sep 2020
Online webinar Facing the harsh reality of pancreatic cancer: policy measures and health system strategies
An online webinar that continued in activities related to the improvement of pancreatic cancer care and the “Bratislava Statement” was held on 9 September 2020 under the umbrella of the iPAAC JA.